Alphatec Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Alphatec Holdings, Inc. on June 27, 2019, covering events occurring on June 21 and June 25, 2019. The filing details a material definitive agreement involving debt financing and equity issuance, as well as a change in the composition of the Board of Directors.
Key Financial Metrics and Transactions
- Debt Financing: The Company completed a draw of $10 million under its Credit, Security and Guaranty Agreement with Squadron Medical Finance Solutions LLC.
- Equity Issuance: In connection with the debt draw, the Company issued warrants to Squadron and Tawani Holdings LLC to purchase an aggregate of 4,838,710 shares of common stock.
- Warrant Terms: The exercise price is $2.17 per share. The warrants are immediately exercisable with a seven-year term and include weighted average anti-dilution adjustments.
- Liquidity and Cash Flow: The filing does not provide specific cash flow statements, balance sheet totals, or liquidity ratios. The $10 million draw represents a direct increase in cash resources.
Material Changes and Governance
The Company appointed Karen McGinnis to its Board of Directors, increasing the total number of directors to eleven. Her term commenced on June 26, 2019. She was also appointed to the Compensation and Special Financing Committees.
Director Compensation:
- Annual Restricted Stock Unit (RSU) award with a grant value of $75,000, pro-rated for the initial term.
- Annual cash retainer of $25,000 for Board membership.
- Additional committee retainers totaling up to $17,250 annually depending on specific committee assignments.
Outlook, Risks, and Contingencies
The filing does not contain forward-looking guidance, revenue projections, or management commentary regarding future operational performance. The primary risk disclosed relates to potential dilution from the warrant exercise and the anti-dilution adjustments, which are capped by Nasdaq listing rules regarding the maximum number of shares issuable.
Investor Verification Checklist
- Verify the current outstanding balance and covenants of the Credit Agreement with Squadron Medical Finance Solutions LLC.
- Confirm the impact of the 4,838,710 warrant shares on fully diluted share count and potential dilution to existing shareholders.
- Review the Registration Rights Agreement (Exhibit 10.2) to understand the Company's obligations to register the resale of warrant shares.
- Assess the Company's cash position post-draw to determine runway and ability to meet operational obligations.